Target Name: ZNF665
NCBI ID: G79788
Review Report on ZNF665 Target / Biomarker Content of Review Report on ZNF665 Target / Biomarker
ZNF665
Other Name(s): Zinc finger protein 665 | ZFP160L | Zinc finger protein 665, transcript variant 4 | Zinc finger protein 665 (isoform 3) | zinc finger protein 665 | ZNF665 variant 4 | ZN665_HUMAN | Zinc finger protein 160-like

ZNF665: A Potential Drug Target and Biomarker for neurodegenerative Disorders

Neurodegenerative diseases are a group of disorders that affect the nervous system and can result in progressive cognitive and motor function loss. These disorders include Alzheimer's disease, Parkinson's disease, Huntington's disease, and other forms of dementia. There is currently no cure for these diseases, and treatments are limited to managing symptoms and improving quality of life. Therefore, the development of new treatments and biomarkers for neurodegenerative diseases is of great interest.

ZNF665: A Potential Drug Target and Biomarker

ZNF665 is a gene that encodes a zinc finger protein 665. It is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell growth, differentiation, and survival. ZNF665 has also been shown to be involved in the development and progression of neurodegenerative diseases.

Potential Drug Target

ZNF665 can be potential drug target for neurodegenerative diseases because of its involvement in various cellular processes that are affected in these diseases. For example, ZNF665 has been shown to be involved in the development of neurogenesis, which is the process by which new neurons are generated in the brain. In neurodegenerative diseases, neurogenesis is disrupted, leading to the loss of neural cells and the progression of the disease.

In addition, ZNF665 has been shown to be involved in the regulation of neuronal stress, which is a critical factor in the development of neurodegenerative diseases. Neuronal stress refers to the damage that occurs to neurons due to various factors, such as oxidative stress, inflammation, and metabolic imbalances. The regulation of neuronal stress is critical for maintaining the health and function of the nervous system, and is disrupted in neurodegenerative diseases.

Biomarker

ZNF665 can also be used as a biomarker for neurodegenerative diseases. The detection and quantification of ZNF665 levels in brain tissue or fluids can provide information about the levels of ZNF665 in the body and its potential levels in the brain. This can be used to monitor the effectiveness of neurodegenerative disease treatments and to track the progression of the disease.

In addition, ZNF665 has been shown to be involved in the development and progression of neurodegenerative diseases, which can be used as a biomarker for these diseases. For example, ZNF665 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease, and has been shown to be overexpressed in the brains of individuals with these diseases.

Conclusion

In conclusion, ZNF665 is a gene that encodes a zinc finger protein 665 that has been shown to play a role in various cellular processes and has been involved in the development and progression of neurodegenerative diseases. The potential drug target and biomarker properties of ZNF665 make it an attractive target for future research and development in the field of neurodegenerative diseases.

Protein Name: Zinc Finger Protein 665

Functions: May be involved in transcriptional regulation

The "ZNF665 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF665 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783